Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 9 | 2006 | 241 | 0.810 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2023 | 46 | 0.810 |
Why?
|
| Bacteriuria | 1 | 2023 | 82 | 0.770 |
Why?
|
| Kidney Neoplasms | 10 | 2006 | 435 | 0.750 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2023 | 167 | 0.700 |
Why?
|
| Vesico-Ureteral Reflux | 5 | 2023 | 81 | 0.660 |
Why?
|
| Ureteral Obstruction | 4 | 2023 | 105 | 0.630 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 300 | 0.620 |
Why?
|
| Cryosurgery | 4 | 2005 | 47 | 0.560 |
Why?
|
| Ureter | 4 | 2023 | 97 | 0.560 |
Why?
|
| Nephrectomy | 4 | 2018 | 178 | 0.530 |
Why?
|
| Kidney Pelvis | 3 | 2021 | 44 | 0.470 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 215 | 0.440 |
Why?
|
| Hypospadias | 3 | 2020 | 78 | 0.430 |
Why?
|
| Kidney | 2 | 2016 | 1356 | 0.390 |
Why?
|
| Neonatal Screening | 3 | 2008 | 184 | 0.350 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2008 | 30 | 0.340 |
Why?
|
| Urology | 2 | 2018 | 75 | 0.340 |
Why?
|
| Serum | 1 | 2010 | 45 | 0.330 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 49 | 0.330 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 80 | 0.320 |
Why?
|
| Carbon | 1 | 2010 | 92 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2096 | 0.320 |
Why?
|
| Prostate | 2 | 2017 | 435 | 0.310 |
Why?
|
| Urethral Diseases | 2 | 2020 | 17 | 0.300 |
Why?
|
| Postoperative Complications | 5 | 2023 | 3071 | 0.300 |
Why?
|
| Bile Acids and Salts | 1 | 2010 | 242 | 0.280 |
Why?
|
| Cortodoxone | 1 | 2007 | 2 | 0.280 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2007 | 4 | 0.280 |
Why?
|
| Laparoscopy | 4 | 2018 | 494 | 0.280 |
Why?
|
| Penis | 2 | 2020 | 98 | 0.270 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2005 | 7 | 0.240 |
Why?
|
| Catheter Ablation | 2 | 2005 | 236 | 0.240 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 639 | 0.240 |
Why?
|
| Retrospective Studies | 15 | 2023 | 16345 | 0.230 |
Why?
|
| Documentation | 2 | 2022 | 115 | 0.220 |
Why?
|
| Infant | 16 | 2022 | 12477 | 0.220 |
Why?
|
| Child | 16 | 2023 | 24410 | 0.210 |
Why?
|
| Urologic Neoplasms | 1 | 2003 | 42 | 0.210 |
Why?
|
| Urinalysis | 1 | 2023 | 61 | 0.200 |
Why?
|
| Hydronephrosis | 3 | 2021 | 35 | 0.190 |
Why?
|
| Penile Diseases | 1 | 2020 | 11 | 0.180 |
Why?
|
| Humans | 38 | 2023 | 124906 | 0.180 |
Why?
|
| Urinary Fistula | 1 | 2020 | 20 | 0.180 |
Why?
|
| Hospitals, Pediatric | 3 | 2020 | 770 | 0.180 |
Why?
|
| Cutaneous Fistula | 1 | 2020 | 23 | 0.180 |
Why?
|
| Reoperation | 3 | 2020 | 833 | 0.170 |
Why?
|
| Nerve Block | 1 | 2020 | 65 | 0.160 |
Why?
|
| Urologic Surgical Procedures | 4 | 2021 | 58 | 0.160 |
Why?
|
| Anesthetics | 1 | 2020 | 79 | 0.160 |
Why?
|
| Child, Preschool | 13 | 2023 | 14019 | 0.160 |
Why?
|
| Urogenital System | 1 | 2019 | 34 | 0.160 |
Why?
|
| Male | 25 | 2020 | 61395 | 0.160 |
Why?
|
| Child Health | 1 | 2019 | 53 | 0.150 |
Why?
|
| Equipment Design | 2 | 2018 | 596 | 0.150 |
Why?
|
| Pediatricians | 1 | 2019 | 69 | 0.150 |
Why?
|
| Pediatrics | 2 | 2018 | 1165 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2010 | 236 | 0.150 |
Why?
|
| Physical Examination | 1 | 2019 | 160 | 0.150 |
Why?
|
| Physicians, Women | 1 | 2018 | 47 | 0.150 |
Why?
|
| Anesthesia | 1 | 2020 | 210 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 729 | 0.140 |
Why?
|
| Prostatic Diseases | 1 | 2017 | 15 | 0.140 |
Why?
|
| Engineering | 1 | 2017 | 5 | 0.140 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2016 | 19 | 0.130 |
Why?
|
| Treatment Outcome | 10 | 2023 | 12405 | 0.130 |
Why?
|
| Spermatic Cord Torsion | 1 | 2016 | 9 | 0.130 |
Why?
|
| Hematuria | 1 | 2016 | 55 | 0.130 |
Why?
|
| Cystitis | 1 | 2016 | 49 | 0.130 |
Why?
|
| Adolescent | 9 | 2023 | 19343 | 0.130 |
Why?
|
| Abscess | 1 | 2017 | 138 | 0.120 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 79 | 0.120 |
Why?
|
| Operating Rooms | 1 | 2016 | 70 | 0.120 |
Why?
|
| Carbonic Anhydrases | 2 | 2006 | 25 | 0.120 |
Why?
|
| Urethra | 1 | 2015 | 84 | 0.120 |
Why?
|
| Injury Severity Score | 1 | 2016 | 227 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 281 | 0.120 |
Why?
|
| Foreskin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 140 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2022 | 723 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2016 | 105 | 0.120 |
Why?
|
| Hydrocolpos | 1 | 2014 | 2 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2016 | 337 | 0.120 |
Why?
|
| Infant, Newborn | 8 | 2018 | 8199 | 0.120 |
Why?
|
| Ureterocele | 1 | 2014 | 4 | 0.120 |
Why?
|
| Skin Transplantation | 1 | 2015 | 60 | 0.120 |
Why?
|
| Female | 19 | 2020 | 66678 | 0.120 |
Why?
|
| Ureteroscopy | 1 | 2014 | 17 | 0.120 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 222 | 0.120 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 154 | 0.110 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 213 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 574 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2428 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 664 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 237 | 0.100 |
Why?
|
| Models, Animal | 2 | 2005 | 465 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2015 | 204 | 0.100 |
Why?
|
| Incidence | 5 | 2020 | 3140 | 0.100 |
Why?
|
| Ultrasonic Therapy | 2 | 2003 | 31 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 558 | 0.100 |
Why?
|
| Chromatography, Liquid | 2 | 2010 | 196 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 949 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2022 | 759 | 0.090 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2003 | 201 | 0.090 |
Why?
|
| Galactosemias | 1 | 2010 | 14 | 0.080 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2010 | 37 | 0.080 |
Why?
|
| Peroxisomal Disorders | 1 | 2010 | 13 | 0.080 |
Why?
|
| Operative Time | 2 | 2020 | 171 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1088 | 0.080 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2008 | 1 | 0.070 |
Why?
|
| Linear Models | 1 | 2010 | 681 | 0.070 |
Why?
|
| Androstenedione | 1 | 2007 | 11 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2016 | 3449 | 0.070 |
Why?
|
| Wound Healing | 2 | 2015 | 457 | 0.070 |
Why?
|
| Calibration | 1 | 2007 | 89 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2007 | 144 | 0.070 |
Why?
|
| Biliary Atresia | 1 | 2010 | 190 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2007 | 217 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 343 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 1179 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3153 | 0.060 |
Why?
|
| Kidney Calices | 1 | 2005 | 4 | 0.060 |
Why?
|
| Kidney Cortex | 1 | 2005 | 20 | 0.060 |
Why?
|
| Needles | 1 | 2005 | 51 | 0.060 |
Why?
|
| Hot Temperature | 1 | 2005 | 137 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 2005 | 92 | 0.060 |
Why?
|
| Necrosis | 1 | 2005 | 208 | 0.060 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2004 | 24 | 0.060 |
Why?
|
| Surgeons | 2 | 2020 | 258 | 0.060 |
Why?
|
| Safety | 1 | 2005 | 217 | 0.060 |
Why?
|
| Dogs | 1 | 2005 | 768 | 0.060 |
Why?
|
| Time Factors | 2 | 2015 | 6320 | 0.060 |
Why?
|
| Prognosis | 5 | 2016 | 4631 | 0.050 |
Why?
|
| Cysts | 1 | 2004 | 101 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 44 | 0.050 |
Why?
|
| Syphilis, Congenital | 1 | 2003 | 28 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2005 | 192 | 0.050 |
Why?
|
| Survival Rate | 4 | 2016 | 2060 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 4808 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2020 | 641 | 0.050 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2003 | 67 | 0.050 |
Why?
|
| Laser Therapy | 1 | 2005 | 249 | 0.050 |
Why?
|
| Cancer Vaccines | 1 | 2004 | 177 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 290 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 520 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 242 | 0.050 |
Why?
|
| Monocytes | 1 | 2004 | 351 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2005 | 468 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2007 | 818 | 0.050 |
Why?
|
| Fatty Acid Desaturases | 1 | 2001 | 8 | 0.050 |
Why?
|
| Swine | 1 | 2005 | 1192 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2004 | 606 | 0.040 |
Why?
|
| Training Support | 1 | 2020 | 17 | 0.040 |
Why?
|
| Nurse Anesthetists | 1 | 2020 | 13 | 0.040 |
Why?
|
| Sacrococcygeal Region | 1 | 2020 | 32 | 0.040 |
Why?
|
| Anesthesia, Caudal | 1 | 2020 | 15 | 0.040 |
Why?
|
| Anesthesiologists | 1 | 2020 | 34 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2881 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2004 | 1278 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 135 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2003 | 461 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2001 | 116 | 0.040 |
Why?
|
| United States | 3 | 2020 | 10909 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2019 | 38 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 420 | 0.040 |
Why?
|
| Patient Selection | 1 | 2003 | 696 | 0.040 |
Why?
|
| Recurrence | 2 | 2018 | 1421 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 388 | 0.040 |
Why?
|
| Dextrans | 1 | 2018 | 45 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 235 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2018 | 303 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 96 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 1148 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1492 | 0.030 |
Why?
|
| Career Choice | 1 | 2018 | 146 | 0.030 |
Why?
|
| Texas | 2 | 2016 | 3586 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 152 | 0.030 |
Why?
|
| Administration, Intravesical | 1 | 2016 | 34 | 0.030 |
Why?
|
| Mentors | 1 | 2018 | 148 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 29 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Cicatrix | 1 | 2018 | 123 | 0.030 |
Why?
|
| Cystoscopy | 1 | 2016 | 44 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 5165 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 78 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2007 | 6155 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 4353 | 0.030 |
Why?
|
| Program Development | 1 | 2017 | 186 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 248 | 0.030 |
Why?
|
| Animals | 3 | 2006 | 34057 | 0.030 |
Why?
|
| Mentoring | 1 | 2017 | 76 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 518 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 138 | 0.030 |
Why?
|
| Colpotomy | 1 | 2014 | 6 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 1216 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 474 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 354 | 0.030 |
Why?
|
| Health Facilities | 1 | 2014 | 60 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 264 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 555 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 1661 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2003 | 1314 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1605 | 0.030 |
Why?
|
| Germany | 2 | 2003 | 65 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2004 | 899 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 10285 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 1397 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 815 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 538 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1178 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1265 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 781 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 2060 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2635 | 0.020 |
Why?
|
| Middle Aged | 5 | 2005 | 26879 | 0.020 |
Why?
|
| Carbonic Anhydrase IX | 1 | 2006 | 12 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 1003 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2004 | 21 | 0.010 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2003 | 14 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 205 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3572 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2004 | 324 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 327 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 9051 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 891 | 0.010 |
Why?
|
| Aged | 3 | 2005 | 19835 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 1101 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 798 | 0.010 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2001 | 3 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2003 | 388 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1016 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 472 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 620 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1507 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1691 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2004 | 940 | 0.010 |
Why?
|
| Adult | 3 | 2005 | 29576 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2004 | 680 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 1290 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3344 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 1624 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 1708 | 0.010 |
Why?
|
| Mass Screening | 1 | 2001 | 783 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 4254 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 5846 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 6588 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 17583 | 0.010 |
Why?
|